Response of High-Risk MDS to Azacitidine and Lenalidomide is Impacted by Baseline and Acquired Mutations in a Cluster of Three Inositide-Specific Genes
| dc.contributor.author | McCubrey, James A. | |
| dc.date.accessioned | 2022-02-04T13:45:38Z | |
| dc.date.available | 2022-02-04T13:45:38Z | |
| dc.date.issued | 2019-09 | |
| dc.identifier.doi | 10.1038/s41375-019-0416-x | |
| dc.identifier.issn | 0887-6924 | |
| dc.identifier.uri | http://hdl.handle.net/10342/9631 | |
| dc.language.iso | en_US | en_US |
| dc.subject | gene mutations | en_US |
| dc.subject | myelodysplastic syndromes (MDS) | en_US |
| dc.subject | azacitidine and lenalidomide | en_US |
| dc.title | Response of High-Risk MDS to Azacitidine and Lenalidomide is Impacted by Baseline and Acquired Mutations in a Cluster of Three Inositide-Specific Genes | en_US |
| dc.type | Article | en_US |
| ecu.journal.issue | 9 | en_US |
| ecu.journal.name | Leukemia | en_US |
| ecu.journal.pages | 2276-2290 | en_US |
| ecu.journal.volume | 33 | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- McCubreyResponseofhighriskMDStoazacitidineandlenalidomide.pdf
- Size:
- 1.83 MB
- Format:
- Adobe Portable Document Format
- Description:
- Article